Furthermore, in addition to MS components or insulin sensitivity, it has been observed in several studies that individuals with MHO display other favorable phenotypic characteristics, such as the absence of hepatic steatosis, lower levels of liver enzymes, interleukin 6 and C-reactive protein compared with the rest of the population with obesity (22, 32–36). The gene discussed is INS; the disease is obesity disorder.